GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JBM (Healthcare) Ltd (HKSE:02161) » Definitions » Gross Profit

JBM (Healthcare) (HKSE:02161) Gross Profit : HK$372.8 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JBM (Healthcare) Gross Profit?

JBM (Healthcare)'s gross profit for the six months ended in Sep. 2024 was HK$205.9 Mil. JBM (Healthcare)'s gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was HK$372.8 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. JBM (Healthcare)'s gross profit for the six months ended in Sep. 2024 was HK$205.9 Mil. JBM (Healthcare)'s Revenue for the six months ended in Sep. 2024 was HK$399.0 Mil. Therefore, JBM (Healthcare)'s Gross Margin % for the quarter that ended in Sep. 2024 was 51.61%.

JBM (Healthcare) had a gross margin of 51.61% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 7 years, the highest Gross Margin % of JBM (Healthcare) was 55.31%. The lowest was 39.50%. And the median was 49.96%.

Warning Sign:

JBM (Healthcare) Ltd gross margin has been in long-term decline. The average rate of decline per year is -3.4%.


JBM (Healthcare) Gross Profit Historical Data

The historical data trend for JBM (Healthcare)'s Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JBM (Healthcare) Gross Profit Chart

JBM (Healthcare) Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial 190.18 198.43 161.51 205.51 338.08

JBM (Healthcare) Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.54 119.97 171.12 166.96 205.89

Competitive Comparison of JBM (Healthcare)'s Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, JBM (Healthcare)'s Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JBM (Healthcare)'s Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JBM (Healthcare)'s Gross Profit distribution charts can be found below:

* The bar in red indicates where JBM (Healthcare)'s Gross Profit falls into.


;
;

JBM (Healthcare) Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

JBM (Healthcare)'s Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=648.415 - 310.334
=338.1

JBM (Healthcare)'s Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=398.953 - 193.065
=205.9

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$372.8 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

JBM (Healthcare)'s Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=205.9 / 398.953
=51.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


JBM (Healthcare)  (HKSE:02161) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

JBM (Healthcare) had a gross margin of 51.61% for the quarter that ended in Sep. 2024 => Durable competitive advantage


JBM (Healthcare) Gross Profit Related Terms

Thank you for viewing the detailed overview of JBM (Healthcare)'s Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


JBM (Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
108 Wai Yip Street, Units 808-811, 8 floor, C-Bons International Centre, Kwun Tong, Kowloon, Hong Kong, HKG
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
Executives
Sum Kwong Yip, Derek
Queenshill Development Limited
Ubs Trustees (b.v.i.) Limited
Kingshill Development Group Inc
Lincoln's Hill Development Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si
New Heritage Healthcare Limited 2101 Beneficial owner
Gavett Limited 2201 Interest of corporation controlled by you
United Islands Group Limited 2201 Interest of corporation controlled by you
Fortstar Limited 2201 Interest of corporation controlled by you
Tao Richard 2201 Interest of corporation controlled by you
Hon Hing Tong Patricia 2202 Interest of your spouse
Tao Paul 2201 Interest of corporation controlled by you
Choi Siu Ping 2202 Interest of your spouse
Longjin Investments Limited 2101 Beneficial owner

JBM (Healthcare) Headlines

No Headlines